Literature DB >> 3726112

Neck neoplasms: MR imaging. Part II. Posttreatment evaluation.

H S Glazer, J H Niemeyer, D M Balfe, R E Hayden, B Emami, V R Devineni, R G Levitt, D J Aronberg, M P Ward, J K Lee.   

Abstract

Thirty-three patients who had undergone prior surgery and/or radiation therapy for malignant neoplasms of the neck were studied with magnetic resonance (MR) imaging. Twenty-seven of these patients were also evaluated with computed tomography (CT). Ten patients were healthy posttreatment volunteers, and 23 had documented tumor recurrence. MR images better demonstrated normal muscular landmarks, especially in patients with obliterated fat planes. Areas of posttreatment fibrosis or scarring were low in signal intensity with all MR pulse sequences. However, in three patients, high signal intensity from postradiation edema of the supraglottic area mimicked neoplasm. In patients with recurrent tumor, MR imaging was superior to CT in defining the relationship of tumor and muscle and in demonstrating vascular anatomy when no intravenous contrast material was given during the CT examination. In two patients tumor and fibrosis were separated on MR images because of signal intensity differences. CT scans, however, showed adjacent bone and cartilage anatomy better. Our data indicate that an MR examination may be helpful in patients in whom CT is indeterminate either because of anatomical distortion or suboptimal demonstration of vascular anatomy.

Entities:  

Mesh:

Year:  1986        PMID: 3726112     DOI: 10.1148/radiology.160.2.3726112

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Normal laryngeal CT findings after supracricoid partial laryngectomy.

Authors:  N Bely-Toueg; P Halimi; O Laccourreye; F Laskri; D Brasnu; G Frija
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Evaluation of head and neck squamous cell carcinoma after treatment.

Authors:  Suresh K Mukherji; Gregory T Wolf
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

Review 3.  Dysphagia after laryngeal surgery: radiologic assessment.

Authors:  D M Balfe
Journal:  Dysphagia       Date:  1990       Impact factor: 3.438

Review 4.  Magnetic resonance imaging of head and neck tumors.

Authors:  R B Lufkin; W Hanafee
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

5.  Pelvic solitary plasmacytoma: computed tomography and magnetic resonance imaging findings with histopathologic correlation.

Authors:  Ying Wang; Xiu-Liang Zhu; Mohamad Wasil Peeroo; Zi-Hua Qian; Dan Shi; Shu-Mei Wei; Ri-Sheng Yu
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

6.  The CT evaluation of neoarytenoid soft tissue after an arytenoidectomy during a supracricoid partial laryngectomy.

Authors:  Dong Il Sun; Bum Soo Kim; So Lyung Jung; Kook Jin Ahn; Min Sik Kim
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

7.  Pre- and post-radiotherapy MRI results as a predictive model for response in laryngeal carcinoma.

Authors:  Redina Ljumanovic; Johannes A Langendijk; Otto S Hoekstra; Dirk L Knol; C René Leemans; Jonas A Castelijns
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

8.  Sonographic findings of the neopharynx after total laryngectomy: comparison with CT.

Authors:  J H Lee; J E Sohn; D H Choe; B H Lee; K H Kim; S Y Chin
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

Review 9.  A review for solitary plasmacytoma of bone and extramedullary plasmacytoma.

Authors:  Sevil Kilciksiz; Omur Karakoyun-Celik; Fulya Yaman Agaoglu; Ayfer Haydaroglu
Journal:  ScientificWorldJournal       Date:  2012-05-02

10.  The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study.

Authors:  Abhishek A Solanki; Ralph R Weichselbaum; Daniel Appelbaum; Karl Farrey; Kamil M Yenice; Steven J Chmura; Joseph K Salama
Journal:  Radiat Oncol       Date:  2012-12-18       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.